Citation Impact
Citing Papers
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease
2009
The gut microbiota and host health: a new clinical frontier
2015 Standout
Inflammatory bowel disease stimulates formation of carcinogenic N -nitroso compounds: Table 1
2005
2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts
2016 Standout
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
2012 Standout
Antifactor Xa activity in critically ill patients receiving antithrombotic prophylaxis with standard dosages of certoparin: a prospective, clinical study
2005
Homocysteine and vascular disease
1999 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
MMX Multi Matrix System® mesalazine for the induction of remission in patients with mild‐to‐moderate ulcerative colitis: a combined analysis of two randomized, double‐blind, placebo‐controlled trials
2007
Dendritic cells in intestinal homeostasis and disease
2009
Dietary Patterns and Self-Reported Associations of Diet with Symptoms of Inflammatory Bowel Disease
2012
The status of vitamins B6, B12, folate, and of homocysteine in geriatric home residents receiving laxatives or dietary fiber
2010
Inflammatory manifestations at colonoscopy in patients with colonic diverticular disease
2010
The role of bacteria and pattern-recognition receptors in Crohn's disease
2011
Importance of mucosal healing in ulcerative colitis
2009
Ulcerative Colitis
2011 Standout
Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure
2015
Nucleotide signalling during inflammation
2014 StandoutNature
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Burden of liver diseases in the world
2018 Standout
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Systematic review: adherence issues in the treatment of ulcerative colitis
2006
Mechanism and Regulation of NLRP3 Inflammasome Activation
2016 Standout
Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis
2010
Diagnostic Precision of Anti-Saccharomyces cerevisiae Antibodies and Perinuclear Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease
2006
Consensus Statements on the Risk, Prevention, and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology
2014
Hypoxia and Inflammation
2011 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Acute-on chronic liver failure
2012
Crohn's disease
2012 Standout
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome
2016 Standout
The Oslo definitions for coeliac disease and related terms
2012 Standout
Hepatocellular carcinoma
2021 Standout
Extraintestinal manifestations in inflammatory bowel disease
2005
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Intestinal Dendritic Cells
2010
Inflammatory Bowel Disease
2009 Standout
Genetics of Inflammatory Bowel Diseases
2015
European evidenced-based consensus on reproduction in inflammatory bowel disease
2010
Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: Results of a multicentric study
2011
From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation
2004
Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery
2005
Portal hypertensive bleeding in cirrhosis
2016 Standout
Ulcerative colitis
2012 Standout
Patient Perception of Treatment Burden Is High in Celiac Disease Compared With Other Common Conditions
2014
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Results of the 2nd part Scientific Workshop of the ECCO (II): Measures and markers of prediction to achieve, detect, and monitor intestinal healing in Inflammatory Bowel Disease
2011
Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2−/−) mice
2007
Polyspecific Organic Cation Transporters: Structure, Function, Physiological Roles, and Biopharmaceutical Implications
2007
Neoplastic and other complications of inflammatory bowel disease
2000
Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease
2007
Diagnostics of Inflammatory Bowel Disease
2007
European evidence-based Consensus on the management of ulcerative colitis: Special situations
2008
Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease
2016
Prevention of Venous Thromboembolism
2004 Standout
Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis
2016
On the role of ischemia in the pathogenesis of IBD
2009
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Ulcerative colitis
2016 Standout
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Non-canonical inflammasome activation targets caspase-11
2011 StandoutNature
Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China
2017
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations
2012
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
2012
Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
2008
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
The endoscopic spectrum of segmental colitis associated with diverticulosis
2009
Prevention of Venous Thromboembolism
2008 Standout
Rising Prevalence of Venous Thromboembolism and Its Impact on Mortality Among Hospitalized Inflammatory Bowel Disease Patients
2008
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
ESPEN Guidelines on Enteral Nutrition: Gastroenterology
2006
Clinical implications of mucosal healing for the management of IBD
2009
Function of Nod‐like receptors in microbial recognition and host defense
2008
Homocysteine Triggers Mucosal Microvascular Activation in Inflammatory Bowel Disease
2005
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease
2014
The Genetics of Inflammatory Bowel Disease
2007
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease
2008 Standout
Increased Risk of Venous Thromboembolic Events With Corticosteroid vs Biologic Therapy for Inflammatory Bowel Disease
2014
Diagnostic difficulties in inflammatory bowel disease pathology
2005
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Segmental Colitis Associated With Diverticular Disease and Other IBD Look-alikes
2006
Clinical states of cirrhosis and competing risks
2017
A nationwide population-based study to determine whether coeliac disease is associated with infertility
2010
Thromboprophylaxis Is Associated With Reduced Post-hospitalization Venous Thromboembolic Events in Patients With Inflammatory Bowel Diseases
2014
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Bowel Ultrasound and Mucosal Healing in Ulcerative Colitis
2009
NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease
2014
Hepatocellular Carcinoma
2019 Standout
Hyperhomocysteinemia, Atherosclerosis and Thrombosis
1999
Single‐centre validation of the EASL ‐CLIF Consortium definition of acute‐on‐chronic liver failure and CLIF ‐SOFA for prediction of mortality in cirrhosis
2014
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
2012
Clinical trial: ulcerative colitis maintenance treatment with 5‐ASA: a 1‐year, randomized multicentre study comparing MMX® with Asacol®
2009
Dietary fibre and fibre-rich by-products of food processing: Characterisation, technological functionality and commercial applications: A review
2010 Standout
Workgroup Report: Drinking-Water Nitrate and Health—Recent Findings and Research Needs
2005 Standout
Inflammatory Bowel Disease: A Canadian Burden of Illness Review
2012
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
2019 Standout
The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications
2009
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Inflammatory Bowel Disease
2010 Standout
Global Epidemiology of Campylobacter Infection
2015 Standout
The interactions between inflammation and coagulation
2005
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn’s Disease Flares
2019 Standout
Exaggerated neurobiological sensitivity to threat as a mechanism linking anxiety with increased risk for diseases of aging
2012
Review article: optimal preparation for surgery in Crohn's disease
2014
Unexpected role of anticoagulant protein C in controlling epithelial barrier integrity and intestinal inflammation
2011
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis
2018 StandoutNobel
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients
2014
Engineering of Kuma030: A Gliadin Peptidase That Rapidly Degrades Immunogenic Gliadin Peptides in Gastric Conditions
2015 StandoutNobel
Works of Simone Saibeni being referenced
Low vitamin B6 plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants
2003
Pregnancy before and after the diagnosis of inflammatory bowel diseases: Retrospective case–control study
2006
Oral, colonic‐release low‐molecular‐weight heparin: an initial open study of Parnaparin‐MMX for the treatment of mild‐to‐moderate left‐sided ulcerative colitis
2008
Variants of OCTN1–2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis
2006
Clinical and laboratory aspects of Ro/SSA-52 autoantibodies
2010
Inflammatory Bowel Diseases Are Not Associated with Major Hereditary Conditions Predisposing to Thrombosis
2000
Thrombosis in Inflammatory Bowel Diseases: Role of Inherited Thrombophilia
2005
Reduced Free Protein S Levels in Patients with Inflammatory Bowel Disease
2001
Val34Leu factor XIII polymorphism in Italian patients with inflammatory bowel disease
2003
Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: A prospective, multicenter study
2011
Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease
2004
Monocyte-derived dendritic cells from Crohn patients show differential NOD2/CARD15-dependent immune responses to bacteria
2008
Segmental colitis associated with diverticula: a prospective study
2000
Impact of Gluten Withdrawal on Health-Related Quality of Life in Celiac Subjects: An Observational Case-Control Study
2010
Mortality Risk According to Different Clinical Characteristics of First Episode of Liver Decompensation in Cirrhotic Patients: A Nationwide, Prospective, 3-Year Follow-Up Study in Italy
2013
Prevalence of Hyperhomocysteinemia in Adult Gluten-Sensitive Enteropathy at Diagnosis: Role of B12, Folate, and Genetics
2005
Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases
2003
Inflammation and Coagulation in Inflammatory Bowel Disease: The Clot Thickens
2006
Gender and disease activity influence health-related quality of life in inflammatory bowel diseases.
2005
Exploring the relationships between inflammatory response and coagulation cascade in inflammatory bowel disease.
2005
Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: Preliminary results of a prospective, multicenter study
2006
High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications?
1998